IRIS PubliCatt

Cingolani, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.176
EU - Europa 2.109
AS - Asia 714
AF - Africa 48
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
Totale 5.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.117
DE - Germania 466
IT - Italia 438
SE - Svezia 436
CN - Cina 245
SG - Singapore 153
FR - Francia 152
UA - Ucraina 133
IE - Irlanda 130
GB - Regno Unito 119
ID - Indonesia 80
IN - India 65
FI - Finlandia 55
PL - Polonia 50
RU - Federazione Russa 49
CA - Canada 42
TR - Turchia 29
IR - Iran 23
AU - Australia 22
BE - Belgio 21
SA - Arabia Saudita 19
NL - Olanda 16
HK - Hong Kong 13
PH - Filippine 13
MX - Messico 12
MY - Malesia 11
PK - Pakistan 11
CI - Costa d'Avorio 10
EG - Egitto 9
VN - Vietnam 8
JP - Giappone 7
CH - Svizzera 6
TN - Tunisia 6
AT - Austria 5
BD - Bangladesh 5
CZ - Repubblica Ceca 5
GR - Grecia 5
NG - Nigeria 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
IL - Israele 4
LT - Lituania 4
MA - Marocco 4
PT - Portogallo 4
ZA - Sudafrica 4
BZ - Belize 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
NO - Norvegia 3
NP - Nepal 3
RO - Romania 3
SD - Sudan 3
TH - Thailandia 3
TW - Taiwan 3
BG - Bulgaria 2
BR - Brasile 2
CM - Camerun 2
CO - Colombia 2
ES - Italia 2
IQ - Iraq 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
TT - Trinidad e Tobago 1
Totale 5.080
Salva come PNG Salva come JPEG
Città #
Chandler 486
Ashburn 167
Dublin 128
New York 116
Rome 111
Singapore 100
Jacksonville 88
Jakarta 80
San Mateo 80
Nanjing 67
Ann Arbor 61
Wilmington 57
Milan 56
Redmond 51
Dearborn 46
Princeton 46
Kraków 45
Chicago 44
Moscow 38
Boston 36
Bremen 33
Boardman 32
Marseille 32
Cattolica 28
Woodbridge 26
Nürnberg 24
Nanchang 23
Izmir 22
Helsinki 21
Houston 20
London 20
Redwood City 20
Lawrence 18
Brussels 17
Fairfield 17
Beijing 16
Lancaster 16
Kunming 15
Los Angeles 14
Norwalk 14
Ottawa 14
Seattle 14
San Jose 13
Fremont 12
Guangzhou 12
Pune 12
Augusta 11
Dammam 11
Munich 11
University Park 11
Abidjan 10
Kish 10
Mountain View 10
Edinburgh 9
Shenyang 9
Amsterdam 8
Changsha 8
Hong Kong 8
Sydney 8
Tianjin 8
Washington 8
Al Qatif 7
Hangzhou 7
Zhengzhou 7
Hebei 6
Oggiono 6
Shanghai 6
Zurich 6
Brno 5
Cairo 5
Council Bluffs 5
Cuauhtémoc 5
Ferrara 5
Jiaxing 5
Lahore 5
Leawood 5
Naples 5
St Louis 5
Swansea 5
Tokyo 5
Auburn Hills 4
Bologna 4
Busto Arsizio 4
Cape Town 4
Castelfranco Emilia 4
Delhi 4
Falls Church 4
Lappeenranta 4
Las Vegas 4
Mumbai 4
Nuremberg 4
Parma 4
Phoenixville 4
Simi Valley 4
Thrissur 4
Toronto 4
Vienna 4
Amman 3
Andover 3
Bacolod City 3
Totale 2.730
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 426
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 195
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 138
Plasma levels of Interleukin-6 and Interleukin-10 in preterm neonates evaluated for sepsis 135
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma 120
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 120
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 118
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 108
Cauda Equina Enhancing Lesion in an HIV-Infected Patient. Case Report and Literature Review. 106
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 104
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 102
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 96
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 96
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis 95
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure 90
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 84
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 83
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy 82
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 82
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 80
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 79
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 78
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 74
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 74
Interpretation systems for genotypic drug resistance of HIV-1 73
Sarilumab use in severe SARS-CoV-2 pneumonia 71
Social media as a tool for scientific updating at the time of COVID pandemic: Results from a national survey in Italy 70
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients 69
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 69
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 67
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 67
Residual respiratory impairment after COVID-19 pneumonia 67
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 65
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 63
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 63
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 63
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 62
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 61
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting 57
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital 56
Clinical implications of HIV-1 drug resistance in the neurological compartment 55
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study 55
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 52
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 52
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 51
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 51
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 50
Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure. 49
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 49
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 48
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 47
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 47
Residual respiratory impairment after COVID-19 pneumonia 46
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition 46
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial” 44
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 43
[Treating HIV disease: back to the patient?] 43
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 43
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 40
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 39
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 38
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials 37
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 36
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 36
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: Data from the ICONA foundation study group, years 1997-2013 34
Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspective 27
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 24
COVID-19 atypical Parsonage-Turner syndrome: a case report 21
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry 20
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19 20
Malnutrition in COVID-19 survivors: prevalence and risk factors 19
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 15
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 15
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 15
Is the rate of virological failure to cART continuing to decline in recent calendar years? 14
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 13
Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study 13
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 13
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 11
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 10
Totale 5.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.829
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020295 0 0 15 15 26 45 28 21 18 21 72 34
2020/2021376 19 31 9 30 31 23 34 14 67 24 77 17
2021/2022669 53 44 14 41 32 20 12 99 33 54 110 157
2022/20231.811 190 187 181 333 174 233 84 95 184 68 61 21
2023/2024901 41 196 36 50 40 163 64 33 20 57 78 123
2024/2025207 36 52 119 0 0 0 0 0 0 0 0 0
Totale 5.189